KR20250075537A - 인간 시르코바이러스의 확인 - Google Patents

인간 시르코바이러스의 확인 Download PDF

Info

Publication number
KR20250075537A
KR20250075537A KR1020247041932A KR20247041932A KR20250075537A KR 20250075537 A KR20250075537 A KR 20250075537A KR 1020247041932 A KR1020247041932 A KR 1020247041932A KR 20247041932 A KR20247041932 A KR 20247041932A KR 20250075537 A KR20250075537 A KR 20250075537A
Authority
KR
South Korea
Prior art keywords
seq
hcirv
protein
nucleic acid
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247041932A
Other languages
English (en)
Korean (ko)
Inventor
필립 뻬로
마끄 엘로이
베아트리스 레그노
니꼴라 다 로샤
안느 쟈메
쟈끄 푸르조
마리안느 르휘에즈-빌
아그네스 페로니
올리비에 로르토라리
끌레르 루조
델핀느 크레띠앙
Original Assignee
앵스띠뛰 파스퇴르
아시스땅스 퍼블리끄-오삐또 드 빠리
유니베르시떼 파리 시테
에꼴 나씨오날르 베떼히네르 달포르
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 앵스띠뛰 파스퇴르, 아시스땅스 퍼블리끄-오삐또 드 빠리, 유니베르시떼 파리 시테, 에꼴 나씨오날르 베떼히네르 달포르 filed Critical 앵스띠뛰 파스퇴르
Publication of KR20250075537A publication Critical patent/KR20250075537A/ko
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/10011Circoviridae
    • C12N2750/10022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/10011Circoviridae
    • C12N2750/10034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
KR1020247041932A 2022-05-18 2023-05-17 인간 시르코바이러스의 확인 Pending KR20250075537A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263343205P 2022-05-18 2022-05-18
US63/343,205 2022-05-18
US202263373343P 2022-08-24 2022-08-24
US63/373,343 2022-08-24
PCT/IB2023/000264 WO2023223092A1 (en) 2022-05-18 2023-05-17 Identification of a human circovirus

Publications (1)

Publication Number Publication Date
KR20250075537A true KR20250075537A (ko) 2025-05-28

Family

ID=86904168

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247041932A Pending KR20250075537A (ko) 2022-05-18 2023-05-17 인간 시르코바이러스의 확인

Country Status (5)

Country Link
EP (1) EP4526478A1 (https=)
JP (1) JP2025516796A (https=)
KR (1) KR20250075537A (https=)
CN (1) CN119585444A (https=)
WO (1) WO2023223092A1 (https=)

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US32011A (en) 1861-04-09 Coffee-pot
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4411993A (en) 1981-04-29 1983-10-25 Steven Gillis Hybridoma antibody which inhibits interleukin 2 activity
US4543439A (en) 1982-12-13 1985-09-24 Massachusetts Institute Of Technology Production and use of monoclonal antibodies to phosphotyrosine-containing proteins
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
US4902614A (en) 1984-12-03 1990-02-20 Teijin Limited Monoclonal antibody to human protein C
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US5333675C1 (en) 1986-02-25 2001-05-01 Perkin Elmer Corp Apparatus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps
DE3689123T2 (de) 1985-11-01 1994-03-03 Xoma Corp Modulare einheit von antikörpergenen, daraus hergestellte antikörper und verwendung.
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
ATE158021T1 (de) 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
CN110527717B (zh) * 2018-01-31 2023-08-18 完美(广东)日用品有限公司 用于2型糖尿病的生物标志物及其用途
US10982187B2 (en) * 2019-03-26 2021-04-20 Genus Plc Bos taurus variety ‘HO840003150607238’ and methods of use thereof
CN109943664A (zh) * 2019-03-27 2019-06-28 天津大学 一种猪圆环病毒3快速检测方法及其试剂盒

Also Published As

Publication number Publication date
WO2023223092A1 (en) 2023-11-23
JP2025516796A (ja) 2025-05-30
EP4526478A1 (en) 2025-03-26
CN119585444A (zh) 2025-03-07

Similar Documents

Publication Publication Date Title
Pankuweit et al. Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens
Pérot et al. Circovirus hepatitis infection in heart-lung transplant patient, France
CN101809033A (zh) 对丙型肝炎病毒(hcv)感染具有抑制活性的抗体和其用途
JPH08509201A (ja) E型肝炎ウィルスワクチン及びその接種方法
WO2023078452A1 (zh) 一种抗登革ns1蛋白的抗体及其应用
JP3061258B2 (ja) 非a非b非c非d非e型肝炎試薬及びそれらの使用方法
Bradley-Dunlop et al. Development of monoclonal antibodies fordetection of necrotizing hepatopancreatitisin penaeid shrimp
KR20250075537A (ko) 인간 시르코바이러스의 확인
Latha et al. Development of recombinant nucleocapsid protein based IgM-ELISA for the early detection of distemper infection in dogs
Buchbinder et al. Mixed lung infection by Legionella pneumophila and Legionella gormanii detected by fluorescent in situ hybridization
EP2413960B1 (en) Diagnostic test for avian nephritis virus
CN114163521A (zh) 一种鉴别猪瘟病毒2.1亚型强毒株及其抗体的单克隆抗体
Xu et al. A Combined Method Based on the FIPV N Monoclonal Antibody Immunofluorescence Assay and RT‐nPCR Method for the Rapid Diagnosis of FIP‐Suspected Ascites
CN117625838A (zh) 一种猫细小病毒的胶体金raa法核酸检测试剂盒及其检测方法
JP2007145775A (ja) ノロウイルスgiの高感度検出方法
KR101349413B1 (ko) 비브리오 패혈증균 알티엑스에이원 항원에 결합하는 단일클론항체 제조와 진단 항원을 제공하기 위한 재조합 단백질 발현벡터
JPH11511027A (ja) Gb型肝炎ウィルス遺伝子型の検出
KR20100105974A (ko) 재조합 n 단백질에 대한 단클론 항체를 이용한 리프트계곡열 경합적 효소결합면역측정법
KR102900600B1 (ko) 리케치아균 검출용 프라이머 세트
KR102900608B1 (ko) 바토넬라균 검출용 프라이머 세트
KR101372766B1 (ko) 비브리오 패혈증균 알티엑스에이원 항원에 결합하는 단일클론항체 제조와 진단 항원을 제공하기 위한 재조합 단백질 발현벡터
RU2548799C1 (ru) Олигонуклеотидные праймеры, днк-зонд и способ для идентификации вируса инфекционной анемии лошадей методом пцр или от-пцр в режиме реального времени
RU2823531C1 (ru) Способ диагностики вирусного репродуктивно-респираторного синдрома свиней с помощью флуоресцентной гибридизации in-situ (fish)
EP3965813B1 (en) A novel orthobunyavirus in human encephalitis and its diagnostic and therapeutic applications
Ha et al. Synthetic peptide-derived antibody-based immunohistochemistry for the detection of porcine circovirus 2 in pigs with postweaning multisystemic wasting syndrome

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20241218

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application